ARK Genomic Revolution ETF (ARKG) price, chart and fund profile
Price chart
Fund profile
ARKG is an actively managed fund that targets companies involved in the genomics industry.
- Issuer
- ARK Investment Management LLC
- Industry
- Theme
- Inception
- Oct 31, 2014
- Expense ratio
- 0.75%
- Net asset value
- $48.42
- NAV as of
- Oct 13, 2026
- Leverage
- 1×
- Fund page
- www.ark-funds.com↗
Frequently asked questions
What is ARK Genomic Revolution ETF (ARKG)?
ARKG is an actively managed fund that targets companies involved in the genomics industry.
What is ARKG's expense ratio?
ARK Genomic Revolution ETF charges an annual expense ratio of 0.75%. The fund is issued by ARK Investment Management LLC.
How large is ARKG?
ARK Genomic Revolution ETF manages $2.0B in assets and has traded since Oct 31, 2014.
How do I buy shares of ARK Genomic Revolution ETF (ARKG)?
ARKG trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.